cisapride has been researched along with Myocardial Infarction in 1 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coloma, PM | 1 |
| Schuemie, MJ | 1 |
| Trifirò, G | 1 |
| Furlong, L | 1 |
| van Mulligen, E | 1 |
| Bauer-Mehren, A | 1 |
| Avillach, P | 1 |
| Kors, J | 1 |
| Sanz, F | 1 |
| Mestres, J | 1 |
| Oliveira, JL | 1 |
| Boyer, S | 1 |
| Helgee, EA | 1 |
| Molokhia, M | 1 |
| Matthews, J | 1 |
| Prieto-Merino, D | 1 |
| Gini, R | 1 |
| Herings, R | 1 |
| Mazzaglia, G | 1 |
| Picelli, G | 1 |
| Scotti, L | 1 |
| Pedersen, L | 1 |
| van der Lei, J | 1 |
| Sturkenboom, M | 1 |
1 other study available for cisapride and Myocardial Infarction
| Article | Year |
|---|---|
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Azithromycin; Betamethasone; Cisapride; Domp | 2013 |